Treatment of chemotherapy-induced thrombocytopenia with monotherapy versus combination therapy: the devil is in the details
Res Pract Thromb Haemost
.
2023 Nov 4;7(8):102250.
doi: 10.1016/j.rpth.2023.102250.
eCollection 2023 Nov.
Author
Hanny Al-Samkari
1
2
Affiliations
1
Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
2
Harvard Medical School, Boston, Massachusetts, USA.
PMID:
38193065
PMCID:
PMC10772883
DOI:
10.1016/j.rpth.2023.102250
No abstract available
Grants and funding
K23 HL159313/HL/NHLBI NIH HHS/United States